Pharm'Up
The Food and Drug Administration (FDA) has approved a second generic version of the abortion medication mifepristone...
A Phase 3 study has demonstrated that SYSA1902 (CSPC Pharmaceutical Group), a biosimilar to the biologic drug...
Amid a complex and often contradictory health care landscape, pharmacists are proving to be essential, front-facing, and...
A multicenter study from South Korea highlights a critical and severe complication of COVID-19: a heightened risk...
Overestimation Alert: Study Suggests CGMs Misrepresent Blood Sugar Impact of Foods in Healthy Adults
Overestimation Alert: Study Suggests CGMs Misrepresent Blood Sugar Impact of Foods in Healthy Adults
A recent study from the University of Bath has raised critical concerns about the accuracy of Continuous...
Respiratory Syncytial Virus (RSV) poses a significant and often underestimated threat to older adults, with recent data...
The 340B Drug Pricing Program, designed to help Covered Entities (CEs)—safety-net providers like Federally Qualified Health Centers...
The Food and Drug Administration (FDA) has granted a supplemental new drug application (sNDA) approval for roflumilast...
Pulmonary arterial hypertension (PAH) is a devastating, rare, and progressive cardiovascular disorder characterized by the constriction of...
The Food and Drug Administration (FDA) is tightening its standards for direct-to-consumer pharmaceutical advertising (DTCA), a move...
